A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CAH / chronic active hepatitis

[Related PubMed/MEDLINE]
Total Number of Papers: 606
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CAH  (>> Co-occurring Abbreviation)
Long Form:   chronic active hepatitis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2016 Molecular characterization of hepatitis B virus among chronic hepatitis B patients from Pointe Noire, Republic of Congo. ASC, AST, HCC, LC
2015 Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection. HBsAg, HBV
2014 Potential mechanisms of hepatitis B virus induced liver injury. ---
2012 Abnormal Gas Diffusing Capacity and Portosystemic Shunt in Patients With Chronic Liver Disease. AV, FEV1, FVC, TLC
2012 Autoimmune hepatitis: what must be said. AIH
2012 Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection. ACLF, ASCs, HBV
2011 Differential expression of haptoglobin isoforms in chronic active hepatitis, cirrhosis and HCC related to HBV infection. HBV, HCC
2011 Prevalence of HBV genotypes among Egyptian hepatitis patients. AH, HBsAg, HCC
2011 Virological and clinical characteristics of hepatitis delta virus in South Asia. AC, CC, HBV, HDV, IP
10  2010 Clinical & molecular characterization of human TT virus in different liver diseases. AVH, FHF, LC, PCR, TTV, UTR
11  2010 Detection of aberrant p16INK4A methylation in sera of patients with HCV-related liver diseases: An Egyptian study. HCC, HCV, LC
12  2009 Effect of fucoidan on the biotinidase kinetics in human hepatocellular carcinoma. HCC, LC
13  2009 Significant influence of the primary liver disease on the outcomes of hepatic retransplantation. PSC
14  2008 Historical reflections on autoimmune hepatitis. AIH, ANA, LKM, SMA
15  2008 Influence of quasispecies on virological responses and disease severity in patients with chronic hepatitis C. CQS, HCC, HVR, NS5B, SQS, SSCP
16  2008 [Association between raised IL-8 serum levels and resistance to combined peg-interferon plus ribavirin therapy in HCV+ active chronic hepatitis]. ---
17  2007 Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. AsC, HBe
18  2007 Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection. HBV
19  2007 Impact of viral hepatitis on apo- and lipoprotein status in blood. HEV
20  2007 Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease. HCV
21  2006 Clinical significance of serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic liver disease. HAI, IV-C, LC, LM, PH, TIMPs
22  2006 Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. HCC, IR
23  2006 Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53. HBV, HBx, HCC
24  2006 Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection. HBsAg, HCV
25  2006 Tumour markers and hepatitis C virus infection in Nigerian patients with liver diseases. AFP, anti-HCV, AP, HBsAg, HCC, LC
26  2005 Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma. FHIT, HCC, HZD, NDT
27  2005 Hepatitis C virus-NS3P in relation to p53, p21waf, mdm2, p21-ras and c-erbB2 in hepatocarcinogenesis. HCC, HCV, MNT, NS3P, RT-PCR
28  2005 Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination. HBV
29  2005 Long-term evolution of liver histopathology in patients with chronic hepatitis C and sustained response. CHC, MU, NR, NS, SR
30  2005 Mutations in the E2-PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma. aa, HCC, HCV, PKR
31  2005 Nitric oxide in patients with chronic liver diseases. CIR, CLD, NO, PHT
32  2005 [Genotyping of hepatitis B virus and its clinical significance in patients with chronic hepatitis B]. HBV, RFLP
33  2004 Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay. ELISA, HCV, LCM
34  2004 Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases. EPO, Hb, ID
35  2004 Serum lipoprotein (a) levels in liver diseases caused by hepatitis. AVH, FHF, LDL
36  2003 Helicobacter pylori infection in patients with Hepatitis C Virus positive chronic liver diseases. H. pylori, HCV
37  2002 Cytokine serum levels in patients with chronic HCV infection. ELISA, HCV, HD, RIBA, RT-PCR, Th
38  2002 Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma. HCC, HCV
39  2002 Superoxide dismutase and total anti-oxidant levels in various forms of liver diseases. AVH, HAV, HBV, HCV, HDV, HEV, SOD, TAO
40  2001 Hepatitis C virus genotyping versus serotyping in Egyptian patients. HCV
41  2001 Influence of IFN-alpha on plasma erythropoietin levels in patients with hepatitis B virus-associated chronic active hepatitis. EPO, HBV, IFN-alpha, s.c
42  2001 Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. Ci, HCV, MMP, TIMP
43  2001 Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood. sFas, sTNFr-II
44  2000 Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Ci, MMPs, MNLs, PMLs
45  2000 Hepatitis C virus genotyping by polymerase chain reaction and DNA enzyme immunoassay among Saudi patients in the Western Province, Saudi Arabia. ALT, EIA, HCV, NLH, RIBA
46  2000 Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma. ASC, HCC, HCV, RT
47  2000 Immunohistochemical study of P53, PCNA and AFP in hepatocellular carcinoma, a comparison between Indonesian and Japanese cases. AFP, HCC
48  2000 Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis. hrIL-6, IL-1, LC, LPS, PBMC
49  2000 Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. CIH, HBV, HCV, LC, MBL
50  2000 Serum interleukin-6 and interferon-gamma levels in patients with hepatitis B-associated chronic liver disease. CPH, HBV, HCC, IFN-gamma, IL-6
51  1999 Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1. CPH, HCC, LC, TIMP, TIMPs
52  1999 Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein. AAL, CH, ChE, HCC, LC, NC
53  1999 Hepatitis C genotypes and subtypes in Saudi Arabia. HCV, RT-PCR
54  1999 Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis. HCV, IL-1ra, RT-PCR
55  1999 Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. ---
56  1999 Low HCV replication levels in end-stage hepatitis C virus-related liver disease. bDNA
57  1999 Mutations in the basal core promoter and precore/core gene of hepatitis B virus in patients with chronic active but not acute hepatitis B. BCP, HBV
58  1999 Natural antibody status in patients with Hashimoto's thyroiditis. NAbs, SLE, TNP
59  1999 Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis. HCC, SRCR
60  1999 Serum pancreatic enzyme concentrations in chronic viral liver diseases. ---
61  1999 [A method for improving the accuracy in measurement of 99mTc-GSA liver uptake]. CPH, LC
62  1998 Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients. AP Cl, HCC
63  1998 Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. ---
64  1998 Determination of hepatic zinc content in chronic liver disease due to hepatitis B virus. CPH
65  1998 Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features. HCV, LB
66  1998 Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients. ALT, IFN-alpha
67  1998 Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease. ---
68  1998 Pulmonary function abnormality in patients with portal hypertension with or without chronic liver disease. ABG, EHPVO
69  1998 Relapsed chronic myeloid leukemia in accelerated phase 10 years after allogeneic bone marrow transplantation: full chimera reconversion with donor peripheral blood stem cells infusion. DLI, IFN-alpha, PBSC
70  1998 The detection of bile ducts in liver biopsies by cytokeratin 7. CK7, FL, H and E, PBC
71  1998 [A study on HBV DNA pre C region A83 mutation in patients with hepatitis B]. CPH, MPCR, RFLP
72  1998 [Clinical significance of telomerase activity in precancerous lesion of the liver (adenomatous hyperplasia)]. AAH, HCC, LC, T-RFs
73  1998 [Hepatotropic delta-virus infection in children]. HDV
74  1998 [Ultrastructural morphometric studies of fat storing cells in human chronic viral hepatitis]. CPH, FSC
75  1997 Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia. HCV, IFN
76  1997 Clinical significance of serum 7S collagen and type VI collagen levels for the diagnosis of hepatic fibrosis. 7S-C, CPH, HCC, LC, RIA, VI-C
77  1997 Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia. alpha-IFN, CHC, CPH
78  1997 Expression of IFN-inducible protein-10 in chronic hepatitis. IP-10, MCP-1
79  1997 Expression of insulin-like growth factor II and its receptor in liver cells from patients with chronic liver diseases. DLC, HBV, HCC, IGF-II, LC
80  1997 Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. ANA, anti-P450IID6, HCV, IAHG
81  1997 Histopathological impacts of hepatitis virus infection in hemodialysis patients: should liver biopsy be performed before renal transplantation? anti-HCV, CPH
82  1997 Incidence of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C. HCC, HCV, IFN
83  1997 Interferon-alpha does not cause significant cardiac dysfunction in patients with chronic active hepatitis. ECG, INF
84  1997 Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. HCV, LH, PCR
85  1997 Non-invasive assessment of inflammatory activity and fibrosis (grade and stage) in chronic hepatitis C infection. CPH, IgG, PIIIP
86  1997 Polymorphism of the fourth component of complement (C4) and three clinical pictures of hepatitis B virus infection in children. GN, GS-S, HBV
87  1997 Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. AAH, AHs, HBV, HCC, HCV, LC, TRF
88  1997 Recent developments in autoimmune liver diseases. APS-1, PBC, PSC
89  1997 Reverse flow in intrahepatic portal vessels and liver function impairment in cirrhosis. IPV, MPV, RF, SMV, SV
90  1997 Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders. CPH
91  1997 Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. HDL, LDL, VLDL
92  1997 The determination of neutrophil membrane fluidity in patients with hepatitis B: a fluorescence polarization study. SFHF
93  1997 [Hot-point mutations of viral C gene during hepatitis B virus infection]. ALC, RFLP
94  1997 [The prevalence of HBsAg in hospitalized children as a marker of hepatitis B virus infection]. HBsAg, HBV, HCV
95  1996 Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. HCC, HCV, IGF-II, mRNA, PCNA, RT-PCR
96  1996 Chronic hepatitis C in elderly patients: clinical, histological and virological features. ALT, AST, CHC, CR, gGT, HAI, HCV-RNA, IFN, LC, PR
97  1996 Chronic liver disease in children on long-term parenteral nutrition. TPN
98  1996 Circulating HCV-RNA, HCV genotype, and liver histology in asymptomatic individuals reactive for anti-HCV antibody and their follow-up study. CPH, PCR
99  1996 Clinical course of concomitant Hbv and Hcv infection in renal allograft recipients. CLD, CPH, HBsAg, HBV, HCV, pts
100  1996 Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C. AST